Roger Glen Berlin
Directeur/Bestuurslid bij Sigrid Therapeutics AB
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Andreas Bhagwani | M | 49 |
Sigrid Therapeutics AB
Sigrid Therapeutics AB Medical SpecialtiesHealth Technology Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden.
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 11 jaar |
Sana Alajmovic | F | - |
Sigrid Therapeutics AB
Sigrid Therapeutics AB Medical SpecialtiesHealth Technology Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden. | 10 jaar |
Tore Bengtsson | M | - |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 11 jaar |
Robert Taflin | M | 55 |
Sigrid Therapeutics AB
Sigrid Therapeutics AB Medical SpecialtiesHealth Technology Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden.
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 11 jaar |
Ulf Arne Wiinberg | M | 66 |
Wyeth Consumer Healthcare, Inc.
Wyeth Consumer Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Consumer Healthcare, Inc. discovers, develops and manufactures health care products. The company is headquartered in Mississauga, Canada.
Sigrid Therapeutics AB
Sigrid Therapeutics AB Medical SpecialtiesHealth Technology Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden. | 4 jaar |
Mattias Giovanni Fili | M | - |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden.
Sigrid Therapeutics AB
Sigrid Therapeutics AB Medical SpecialtiesHealth Technology Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden. | 11 jaar |
Tore Bengtsson | M | - |
Sigrid Therapeutics AB
Sigrid Therapeutics AB Medical SpecialtiesHealth Technology Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden. | 10 jaar |
Mats Georg Arnhög | M | 73 |
Sigrid Therapeutics AB
Sigrid Therapeutics AB Medical SpecialtiesHealth Technology Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden. | - |
Carl-Johan Spak | M | 68 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 7 jaar |
Anders Olof Adolf Ekblom | M | 70 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 2 jaar |
Kai Gerrit Björn Gruner | M | 59 |
Sigrid Therapeutics AB
Sigrid Therapeutics AB Medical SpecialtiesHealth Technology Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden. | 7 jaar |
Mattias Ankarberg | M | 48 |
Sigrid Therapeutics AB
Sigrid Therapeutics AB Medical SpecialtiesHealth Technology Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden. | - |
Maarten de Château | M | 61 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 7 jaar |
Sangwoo Lee | M | 52 |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 5 jaar |
Alexandra Ekman Ryding | M | - |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | 6 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
William F. Hamilton | M | 84 | - | |
Scott Fields | M | 69 | 2 jaar | |
Kenneth J. Martin | M | 70 |
Wyeth Consumer Healthcare, Inc.
Wyeth Consumer Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Consumer Healthcare, Inc. discovers, develops and manufactures health care products. The company is headquartered in Mississauga, Canada. | - |
Cavan Redmond | M | 63 |
Wyeth Consumer Healthcare, Inc.
Wyeth Consumer Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Consumer Healthcare, Inc. discovers, develops and manufactures health care products. The company is headquartered in Mississauga, Canada. | 2 jaar |
Stephen A. Cooper | M | - |
Wyeth Consumer Healthcare, Inc.
Wyeth Consumer Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Consumer Healthcare, Inc. discovers, develops and manufactures health care products. The company is headquartered in Mississauga, Canada. | 10 jaar |
Stefan Proniuk | M | 53 | 9 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Zweden | 15 | 71.43% |
Canada | 4 | 19.05% |
Verenigde Staten | 3 | 14.29% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Roger Glen Berlin
- Persoonlijk netwerk